Innovative TB risk scoring tool enhances patient care and workflow

Caitlin Dugdale, MD, MSc, and Kimon Zachary, MD, physicians in the Division of Infectious Diseases at Massachusetts General Hospital (MGH) and assistant professors of Medicine at Harvard Medical School, are co-lead authors of a new study in Infection Control and Hospital Epidemiology, TB or Not TB? Development and Validation of a Clinical Decision Support System for the Evaluation of Suspected Tuberculosis.

Early Smoking Cessation After Cancer Diagnosis Tied to Better Survival

Smokers who quit after a cancer diagnosis had increased survival, with the greatest benefit for those who initiated smoking cessation treatment within 6 months, a

November 1, 2024

COVID Drug and New Mutations; Costco Offers $29 Care; Trump Unmasked Over Bronzer

Note that some links may require registration or subscription. The COVID-19 antiviral molnupiravir (Lagevrio) was linked with new mutations of the virus. (Nature) Spending opioid

September 27, 2023

In surprise move, FDA delays decision on Lilly’s Alzheimer’s drug, will convene advisory committee

The FDA has pushed back its decision on Eli Lilly’s highly anticipated Alzheimer’s drug donanemab and plans to convene an advisory committee to review it,

March 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.